At 3.9% CAGR, the Middle East & Africa Cold Pain Therapy Market is Projected to be Worth US$ 86.46 million by 2028, says Business Market Insights

According to Business Market Insights research, the Middle East & Africa cold pain therapy market was valued at US$ 68.79 million in 2022 and is expected to reach US$ 86.46 million by 2028, registering a CAGR of 3.9% from 2022 to 2028. Increasing sports injuries and orthopedic surgeries as well as significant rise in elderly and obese population attributed to the Middle East & Africa Cold pain therapy market expansion.  

Cold pain therapy includes using cold material, such as cold packs, for pain management, which also helps reduce swelling, muscle spasms, and inflammation. The emerging economies have a large patient pool of geriatric and obese people that are prone to orthopedic conditions. Moreover, an increase in healthcare expenditure leading to the development of healthcare services and infrastructure and a rise in medical tourism is expected to create significant opportunities for the Middle East & Africa cold pain therapy market. In addition, an increase in road accidents and trauma cases in developing economies is likely to create demand for cold pain therapy. Thus, there is a high adoption of cold pain therapy in emerging economies.

On the contrary, lack of awareness, unfavourable reimbursement scenarios and side effects of cold pain therapy hampers the Middle East & Africa cold pain therapy market.  

Based on application, the Middle East & Africa cold pain therapy market is segmented into runner's knee, tendonitis, sprains/sports sprain, arthritis pain, pain & swelling after a hip or knee replacement, pain & swelling under a cast or a splint, surgery recovery, lower back pain, and others. The surgery recovery segment held 31.9% share of Middle East & Africa cold pain therapy market in 2022, amassing US$ 21.94 million. It is projected to garner US$ 28.52 million by 2028 to expand at 4.5% CAGR during 2022–2028. 

Based on offering, the Middle East & Africa cold pain therapy market is segmented into over the counter, prescription products, rehabilitation exercises, ice wraps & cold packs, pads, compression therapy, and others. The prescription products segment held 36.5% share of Middle East & Africa cold pain therapy market in 2022, amassing US$ 25.13 million. It is projected to garner US$ 32.58 million by 2028 to expand at 4.4% CAGR during 2022–2028.

Based on end user, the Middle East & Africa cold pain therapy market is segmented into hospitals, clinics, rehabilitation centers, ambulatory surgical centers, individuals, and others. The hospitals segment held 40.1% share of Middle East & Africa cold pain therapy market in 2022, amassing US$ 27.56 million. It is projected to garner US$ 33.76 million by 2028 to expand at 3.4% CAGR during 2022–2028.

Based on country, the Middle East & Africa cold pain therapy market has been categorized into the Saudi Arabia, UAE, South Africa, and the Rest of Middle East and Africa. Our regional analysis states that the Saudi Arabia captured Saudi Arabia 34.0% share of Middle East & Africa cold pain therapy market in 2022. It was assessed at US$ 23.35 million in 2022 and is likely to hit US$ 28.83 million by 2028, exhibiting a CAGR of 3.6% during 2022–2028.      

Key players operating in the Middle East & Africa cold pain therapy market are DJO Global Inc, Ossur hf, Cardinal Health Inc, Johnson & Johnson Services Inc, and Beiersdorf, among others.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com